Graft SurvivalKidney TransplantationGraft RejectionSurvival RateDiabetic RetinopathyDiabetic NephropathiesCell SurvivalTissue DonorsImmunosuppressive AgentsLiver TransplantationCadaverTreatment OutcomeDiabetes Mellitus, ExperimentalTime FactorsRetrospective StudiesTransplantation, HomologousPancreas TransplantationLiving DonorsGraft Occlusion, VascularCorneal TransplantationSurvival AnalysisHeart TransplantationDiabetic AngiopathiesKeratoplasty, PenetratingTissue and Organ ProcurementDiabetic FootTacrolimusIslets of Langerhans TransplantationDisease-Free SurvivalFollow-Up StudiesHistocompatibility TestingDiabetes Mellitus, Type 1ImmunosuppressionSkin TransplantationCyclosporineDelayed Graft FunctionCold IschemiaPostoperative ComplicationsSurvivalOrgan PreservationKaplan-Meier EstimatePregnancy in DiabeticsMycophenolic AcidBrain DeathDiabetes Mellitus, Type 2TransplantsReoperationTransplantation ToleranceRisk FactorsProportional Hazards ModelsTransplantation, HeterotopicKidney Failure, ChronicGraft Enhancement, ImmunologicMice, Inbred C57BLKidneyLiver FailureStreptozocinDiabetes MellitusBlood Vessel ProsthesisBlood GlucosePrimary Graft DysfunctionAntilymphocyte SerumDeathTransplantation ImmunologyRats, Inbred LewAzathioprineHLA AntigensIsoantibodiesPolytetrafluoroethyleneProspective StudiesCreatinineMice, Inbred BALB CMultivariate AnalysisOrgan Preservation SolutionsInsulinRecurrenceDiabetes ComplicationsDonor SelectionDiabetic CardiomyopathiesBiopsyPrognosisTransplantation, IsogeneicTransplantationAnastomosis, SurgicalAge FactorsDisease Models, AnimalTissue and Organ HarvestingHistocompatibilityCohort StudiesCorneal NeovascularizationMice, Inbred NODVascular PatencyDrug Therapy, CombinationRisk AssessmentAntibodies, MonoclonalImmunohistochemistryIncidenceComplement C4bApoptosisRaffinose